CytoSorbents Corporation (CTSO)

[fantomphan]

$11.5 million in sales was good, no doubt. But it wasn't unexpected, or something that would draw attention to us. And the portion of it connected to Covid is viewed as temporary by the market. How temporary is anybody's guess as it's still expanding. The hiring of Dr. Makis was a big positive. The hiring of Medtronic's sales guru Komsa should be viewed as an indication that FDA will be happening relatively soon. But the failure to keep us updated, or to meet deadlines for promised updates, has people gun shy. After some good recent news, it remains that the two items that may move the needle, REMOVE and FDA, remain unknown. We need that news and we need this upcoming shareholders letter to be bold and dynamic (and I realize this is not what the people in charge here are all about). Ready to rock in 2021. Let's go already!